Evidence map›Paper›PMID 26798400›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

The Consumption of Bicarbonate-Rich Mineral Water Improves Glycemic Control.

Shinnosuke Murakami, Yasuaki Goto, Kyo Ito, Shinya Hayasaka, Shigeo Kurihara, Tomoyoshi Soga, Masaru Tomita, Shinji Fukuda

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04632277 (Daily Intake of Magnesium From Drinking Water in Relation to Diabetes Mellites), which is not on this map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04632277 nacompletednot on this mapstarted 2020, after this paper: background citation

Daily Intake of Magnesium From Drinking Water in Relation to Diabetes Mellites

TypeinterventionalSponsorImam Abdulrahman Bin Faisal UniversityRan2020 to 2021Enrolled102ConditionsDiabetes Mellitus, Patients, Glucose, High BloodArmsWater, Water with low Mg, Water with high Mg
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Effect ofDermatopathology (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shinnosuke MurakamiSystems Biology Program, Graduate School of Media and Governance, Keio University, 5322 Endo, Fujisawa, Kanagawa 252-0882, Japan; Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Yasuaki GotoOnsen Medical Science Research Center, Japan Health and Research Institute, 1-29-4 Kakigaracho, Nihonbashi, Chuo-ku, Tokyo 103-0014, Japan.
Kyo ItoIto Medical Office, 7985-5, Nagayu, Naoirimachi, Taketa, Oita 878-0402, Japan.
Shinya HayasakaOnsen Medical Science Research Center, Japan Health and Research Institute, 1-29-4 Kakigaracho, Nihonbashi, Chuo-ku, Tokyo 103-0014, Japan; Faculty of Human Life Sciences, Tokyo City University, 8-9-18 Todoroki, Setagaya-ku, Tokyo 158-8586, Japan.
Shigeo KuriharaOnsen Medical Science Research Center, Japan Health and Research Institute, 1-29-4 Kakigaracho, Nihonbashi, Chuo-ku, Tokyo 103-0014, Japan.
Tomoyoshi SogaSystems Biology Program, Graduate School of Media and Governance, Keio University, 5322 Endo, Fujisawa, Kanagawa 252-0882, Japan; Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Masaru TomitaSystems Biology Program, Graduate School of Media and Governance, Keio University, 5322 Endo, Fujisawa, Kanagawa 252-0882, Japan; Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Shinji FukudaSystems Biology Program, Graduate School of Media and Governance, Keio University, 5322 Endo, Fujisawa, Kanagawa 252-0882, Japan; Institute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Keio University · JPKeio University Shonan Fujisawa · JPTokyo City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hot spring water and natural mineral water have been therapeutically used to prevent or improve various diseases. Specifically, consumption of bicarbonate-rich mineral water (BMW) has been reported to prevent or improve type 2 diabetes (T2D) in humans. However, the molecular mechanisms of the beneficial effects behind mineral water consumption remain unclear. To elucidate the molecular level effects of BMW consumption on glycemic control, blood metabolome analysis and fecal microbiome analysis were applied to the BMW consumption test. During the study, 19 healthy volunteers drank 500 mL of commercially available tap water (TW) or BMW daily. TW consumption periods and BMW consumption periods lasted for a week each and this cycle was repeated twice. Biochemical tests indicated that serum glycoalbumin levels, one of the indexes of glycemic controls, decreased significantly after BMW consumption. Metabolome analysis of blood samples revealed that 19 metabolites including glycolysis-related metabolites and 3 amino acids were significantly different between TW and BMW consumption periods. Additionally, microbiome analysis demonstrated that composition of lean-inducible bacteria was increased after BMW consumption. Our results suggested that consumption of BMW has the possible potential to prevent and/or improve T2D through the alterations of host metabolism and gut microbiota composition.

Identifiers

PMID26798400
PMCPMC4698932
OpenAlexW2211071659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.